• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Vibegron Intermediate CAS:1421271-01-3
Food Grade Fish Collagen
Vibegron Intermediate CAS:1295539-30-8
Vibegron Intermediate CAS:1426235-01-9
Vibegron Intermediate CAS:163625-46-5
Vibegron Intermediate

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

expresspharmaJune 24, 2021

Tag: Dr Reddy’s , Icosapent Ethyl capsules , triglyceride

Dr Reddy’s Laboratories 21st launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.

Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Previous:Turkish COVID-19 vaccine starts phase-III trials

Next:Adroit Biomed develops orally-dissolving mini effervescent tablet to prevent, manage and recover from COVID-19

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Medium Chain Triglyceride

Medium Chain Triglyceride
Triglyceride

Triglyceride
Medium chain triglycerides Powder(Coconut oil)

Medium chain triglycerides Powder(Coconut oil)
MCT Oil（Medium Chain Triglycerides）

MCT Oil（Medium Chain Triglycerides）
Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides

Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides
Medium chain triglyceride microcapsule powder

Medium chain triglyceride microcapsule powder
Miglyol -812 (triglycerides of capric/caprylic acids)

Miglyol -812 (triglycerides of capric/caprylic acids)
Omega-3 Triglycerides

Omega-3 Triglycerides
omega-3-acid triglycerides

omega-3-acid triglycerides
Medium chain triglycerides Powder(palm oil)

Medium chain triglycerides Powder(palm oil)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service